Remel, Inc recalls remel BLOOD AGAR EMB AGAR BIPLATE and 1 more
- Published
- 26 Feb 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Product may contain surface and subsurface contamination of Listeria monocytogenes which is typically visible immediately upon removal from the packaging, appearing on the blood side of the biplate.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use
remel BLOOD AGAR MacCONKEY AGAR BIPLATE, REF R02049, QTY 100, for invitro diagnostic use
- Brand / company
- Remel, Inc
- Codes / lots
- UDI/DI 848838003684, Lot Number 213971, exp. 2025-02-25 | UDI/DI 848838003691, Lot Number 213926, exp. 2025-02-24
- Distribution
- US Nationwide distribution.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 26 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.